Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japan
Clinical trial NCT02531867 · COMPLETED
Trial details
- NCT number
- NCT02531867
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2015-11-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.